The risk was evident even among people who did not need hospitalization during the acute phase of SARS-CoV-2 infection — this group represents most people with COVID-19
Given the large number of people with COVID-19, these absolute numbers might translate into substantial population-level burden and could further strain already overwhelmed health systems
International bodies, national governments, and health systems must develop and implement strategies for early identification and treatment of affected individuals.
In a cohort of more than 153 k people with COVID-19, 5.6 million contemporary controls, and 5.8 million historical controls without evidence of infection
We show increased risks of a wide range of cardiovascular diseases at 1 year
These include cerebrovascular disorders, dysrhythmias, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure and thromboembolic disease.
#Longcovid is a multifaceted disease; it can affect multiple organ systems including respiratory, cardiovascular, nervous, mental health, metabolic, gastrointestinal, kidneys, and other organ systems.
People with #longcovid have increased risk of incident use of several therapeutics including pain medications (opioids and non-opioids), antidepressants, anxiolytics, antihypertensives, and oral antihyperglycemics and evidence of laboratory abnormalities in multiple organ systems